Site Search

... some rare cancers. If clinical trials demonstrate benefit and the FDA approves, these types of tests would be an incredible asset in cancer care and have the potential to save countless lives. I am thrilled at the prospect that my patients — and those of my colleagues — might be ... all the more critical. This bill, which has received bipartisan support and co-sponsorship from 54 senators, would also give the Secretary of Health and Human Services authority to cover new multi-cancer technology in the future, without the need for additional legislation. In focusing on this groundbreaking technology, policymakers in Washington signal to their constituents that early detection and patient health are priorities. As a practitioner in and resident of Delaware, I applaud Sen. Tom Carper and Sen. Chris Coons’ and Rep. Lisa Blunt ...